ArticleArchives of osteoporosis2025
Real-life effectiveness of a Fracture Liaison Service in reducing short-term mortality and second fractures after hip fracture: a five-year prospective study.
Article in Archives of osteoporosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We evaluated the long-term impact of a Fracture Liaison Service (FLS) in elderly hip fracture patients. FLS implementation improved one-year survival and significantly reduced the risk of secondary fractures in adherent patients. However, no significant differences in five-year mortality were observed. Structured care improves short-term outcomes and treatment adherence. PURPOSE: Hip fractures are the most serious type of fragility fractures, as they are associated with increased short- and long-term all-cause mortality. The implementation of Fracture Liaison Service (FLS) programs has improved the management of osteoporosis-related fractures and demonstrated clinical effectiveness. This study aimed to evaluate the impact of an FLS model on survival rates, mortality reduction, and secondary fracture prevention over a five-year period.
methodsWe conducted a prospective cohort study on patients aged 60 years and older who sustained a hip fracture before and after FLS implementation at our centre (January 2016-December 2019). Patients were followed for five years. Mortality, complications, and secondary fractures were analysed using a multivariate Cox proportional hazards model.
resultsA total of 1,401 patients were included (355 pre-FLS and 1,046 post-FLS). The prescription of anti-osteoporotic drugs significantly increased after FLS implementation (77.5% vs. 12.1%; p < 0.01), as did adherence to treatment (48.9% vs. 30.2%; p = 0.02). One-year mortality was lower in the post-FLS group [18.3% vs. 22.0%; adjusted HR 0.77 (0.60-0.99); p = 0.045]. However, five-year mortality rates showed no significant differences between groups (59.1% vs. 54.6%; p = 0.14). Patients adherent to osteoporosis treatment had a significantly lower risk of secondary fractures (10.8% vs. 19.1%; p < 0.01).
conclusionImplementing an FLS protocol was associated with a significant reduction in one-year mortality and improved adherence to osteoporosis treatment, leading to a lower risk of secondary fractures. However, no significant difference was observed in overall five-year mortality.
Indexed as
Identifiers
40987981What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.